Fibrodysplasia Ossificans Progressiva (FOP) Completed Phase 3 Trials for Palovarotene (DB05467)

Also known as: FOP / Fibrodysplasia Ossificans Progressiva / Myositis ossificans progressiva, unspecified site / Myositis ossificans progressiva / Progressive myositis ossificans / Progressive myositis ossificans (disorder)

IndicationStatusPhase
DBCOND0086420 (Fibrodysplasia Ossificans Progressiva (FOP))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03312634An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.Treatment